In the present study, we provide evidence that cerebral Aβ peptide deposition is markedly reduced when PLTP is deleted in a hAPP transgenic mouse model of AD, which can be explained by an increase in Aβ clearance mechanisms. Here, PLTP is linked to Alzheimer disease.